EnerSpar Corp. (TSE:NRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NurExone Biologic Inc. has received a Notice of Allowance from the Israel Patent Office for its ExoPTEN patent, a key component in its regenerative medicine therapy for acute spinal cord injuries. The company is advancing its ExoPTEN nanodrug towards clinical trials and has also partnered with Allele Capital Partners for investor relations services, with plans to increase engagement and potentially uplist to major stock exchanges.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
